Vanderbilt University divulges new muscarinic M4 receptor PAMs
July 4, 2025
Vanderbilt University has synthesized muscarinic M4 receptor positive allosteric modulators (PAMs) reported to be useful for the treatment of Alzheimer’s disease, pain, schizophrenia and sleep disorders.